ベシフロキサシン塩酸塩
- ¥26400 - ¥322600
- 化学名: ベシフロキサシン塩酸塩
- 英語名: Besifloxacin hydrochloride
- 別名:ベシフロキサシン塩酸塩
- CAS番号: 405165-61-9
- 分子式: C19H22Cl2FN3O3
- 分子量: 430.3
- EINECS:696-612-6
- MDL Number:MFCD14636632
5物価
選択条件:
ブランド
- 富士フイルム和光純薬株式会社(wako)
パッケージ
- 10mg
- 25mg
- 50mg
- 100mg
- 200mg
- 生産者富士フイルム和光純薬株式会社(wako)
- 製品番号W01TRCB319000
- 製品説明ベシフロキサシン塩酸塩
- 英語製品説明Besifloxacin Hydrochloride
- 包装単位10mg
- 価格¥26400
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式会社(wako)
- 製品番号W01TRCB319000
- 製品説明ベシフロキサシン塩酸塩
- 英語製品説明Besifloxacin Hydrochloride
- 包装単位25mg
- 価格¥50400
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式会社(wako)
- 製品番号W01TRCB319000
- 製品説明ベシフロキサシン塩酸塩
- 英語製品説明Besifloxacin Hydrochloride
- 包装単位50mg
- 価格¥95100
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式会社(wako)
- 製品番号W01TRCB319000
- 製品説明ベシフロキサシン塩酸塩
- 英語製品説明Besifloxacin Hydrochloride
- 包装単位100mg
- 価格¥161200
- 更新しました2023-06-01
- 購入
- 生産者富士フイルム和光純薬株式会社(wako)
- 製品番号W01TRCB319000
- 製品説明ベシフロキサシン塩酸塩
- 英語製品説明Besifloxacin Hydrochloride
- 包装単位200mg
- 価格¥322600
- 更新しました2023-06-01
- 購入
生産者 | 製品番号 | 製品説明 | 包装単位 | 価格 | 更新時間 | 購入 |
---|---|---|---|---|---|---|
富士フイルム和光純薬株式会社(wako) | W01TRCB319000 | ベシフロキサシン塩酸塩 Besifloxacin Hydrochloride |
10mg | ¥26400 | 2024-03-01 | 購入 |
富士フイルム和光純薬株式会社(wako) | W01TRCB319000 | ベシフロキサシン塩酸塩 Besifloxacin Hydrochloride |
25mg | ¥50400 | 2024-03-01 | 購入 |
富士フイルム和光純薬株式会社(wako) | W01TRCB319000 | ベシフロキサシン塩酸塩 Besifloxacin Hydrochloride |
50mg | ¥95100 | 2024-03-01 | 購入 |
富士フイルム和光純薬株式会社(wako) | W01TRCB319000 | ベシフロキサシン塩酸塩 Besifloxacin Hydrochloride |
100mg | ¥161200 | 2023-06-01 | 購入 |
富士フイルム和光純薬株式会社(wako) | W01TRCB319000 | ベシフロキサシン塩酸塩 Besifloxacin Hydrochloride |
200mg | ¥322600 | 2023-06-01 | 購入 |
プロパティ
融点 :>210°C (dec.)
貯蔵温度 :Inert atmosphere,2-8°C
溶解性 :Methanol (Slightly, Heated, Sonicated), Water (Slightly, Heated, Sonicated)
外見 :Solid
色 :Off-White to Light Beige
貯蔵温度 :Inert atmosphere,2-8°C
溶解性 :Methanol (Slightly, Heated, Sonicated), Water (Slightly, Heated, Sonicated)
外見 :Solid
色 :Off-White to Light Beige
安全情報
絵表示(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
注意喚起語: | Warning | ||||||||||||||||||||||||||||
危険有害性情報: |
|
||||||||||||||||||||||||||||
注意書き: |
|
説明
Besifloxacin is a new fluoroquinolone antibacterial for ophthalmic use. It is indicated for the treatment of bacterial conjunctivitis, one of the most common ocular infections encountered in the primary care setting. Although the previously marketed fluoroquinolones ciprofloxacin, levofloxacin, ofloxacin, gatifloxacin, and moxifloxacin have been widely used to treat bacterial conjunctivitis, their continued utility is hampered by the emergence of resistance among key ocular isolates such as Staphylococcus aureus. Besifloxacin is the first fluoroquinolone developed exclusively for topical ophthalmic use. Unlike the previously marketed fluoroquinolones, besifloxacin has not been used systemically and is not in development as a systemic agent. Its exclusive indication as a topical agent is expected to reduce the overall environmental exposure of bacteria to besifloxacin, which may contribute to a lower risk for the emergence of bacterial resistance. Fluoroquinolones derive their antibacterial activity via inhibition of two essential bacterial enzymes, DNA gyrase and topoisomerase IV, which regulate processes of DNA replication. Besifloxacin inhibits DNA gyrase and topoisomerase IV from Streptococcus pneumoniae (IC50 = 1 and 0.4 mg/ L, respectively) and Escherichia coli (IC50 = 1 and 10 mg/L, respectively).関連商品価格
- ガチフロキサシン
¥12500-151100 - モキシフロキサシン塩酸塩
¥15800-263500 - アリセルチブ
¥17500-757600